annual cash & cash equivalents:
$183.58M+$75.63M(+70.05%)Summary
- As of today (June 2, 2025), KNSA annual cash & cash equivalents is $183.58 million, with the most recent change of +$75.63 million (+70.05%) on December 31, 2024.
- During the last 3 years, KNSA annual cash & cash equivalents has risen by +$61.11 million (+49.90%).
- KNSA annual cash & cash equivalents is now at all-time high.
Performance
KNSA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$157.13M-$26.45M(-14.41%)Summary
- As of today (June 2, 2025), KNSA quarterly cash & cash equivalents is $157.13 million, with the most recent change of -$26.45 million (-14.41%) on March 31, 2025.
- Over the past year, KNSA quarterly cash & cash equivalents has increased by +$16.05 million (+11.38%).
- KNSA quarterly cash & cash equivalents is now -44.97% below its all-time high of $285.52 million, reached on June 30, 2018.
Performance
KNSA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KNSA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.0% | +11.4% |
| 3 y3 years | +49.9% | +148.1% |
| 5 y5 years | +291.2% | +47.8% |
KNSA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.0% | -14.4% | +148.1% |
| 5 y | 5-year | at high | +291.2% | -17.4% | +148.1% |
| alltime | all time | at high | +303.0% | -45.0% | +244.9% |
KNSA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $157.13M(-14.4%) |
| Dec 2024 | $183.58M(+70.1%) | $183.58M(+88.5%) |
| Sep 2024 | - | $97.38M(-1.9%) |
| Jun 2024 | - | $99.27M(-29.6%) |
| Mar 2024 | - | $141.08M(+30.7%) |
| Dec 2023 | $107.95M(-12.0%) | $107.95M(-8.4%) |
| Sep 2023 | - | $117.83M(+4.7%) |
| Jun 2023 | - | $112.57M(+39.6%) |
| Mar 2023 | - | $80.62M(-34.3%) |
| Dec 2022 | $122.72M(+0.2%) | $122.72M(-30.2%) |
| Sep 2022 | - | $175.76M(+86.4%) |
| Jun 2022 | - | $94.31M(+48.9%) |
| Mar 2022 | - | $63.32M(-48.3%) |
| Dec 2021 | $122.47M | $122.47M(-35.6%) |
| Sep 2021 | - | $190.18M(+13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $167.95M(+40.1%) |
| Mar 2021 | - | $119.86M(+5.1%) |
| Dec 2020 | $114.04M(+143.0%) | $114.04M(+32.8%) |
| Sep 2020 | - | $85.87M(-30.4%) |
| Jun 2020 | - | $123.46M(+16.1%) |
| Mar 2020 | - | $106.34M(+126.6%) |
| Dec 2019 | $46.93M(-34.8%) | $46.93M(-31.8%) |
| Sep 2019 | - | $68.81M(-16.9%) |
| Jun 2019 | - | $82.81M(+0.2%) |
| Mar 2019 | - | $82.63M(+14.8%) |
| Dec 2018 | $71.98M(+58.0%) | $71.98M(+3.3%) |
| Sep 2018 | - | $69.66M(-75.6%) |
| Jun 2018 | - | $285.52M(+29.1%) |
| Mar 2018 | - | $221.11M(+385.4%) |
| Dec 2017 | $45.55M(-18.6%) | $45.55M |
| Dec 2016 | $55.97M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is Kiniksa Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of KNSA is $183.58M
What is the all time high annual cash & cash equivalents for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual cash & cash equivalents is $183.58M
What is Kiniksa Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, KNSA annual cash & cash equivalents has changed by +$75.63M (+70.05%)
What is Kiniksa Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of KNSA is $157.13M
What is the all time high quarterly cash & cash equivalents for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly cash & cash equivalents is $285.52M
What is Kiniksa Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, KNSA quarterly cash & cash equivalents has changed by +$16.05M (+11.38%)